Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Pick a track — progress rings update as you complete lessons.
17 lessons
7mKLOW combines BPC-157, TB-500, and GHK-Cu in a single vial. Here's how it works, what to expect, and when separate pins are the better call.
10mOrthopaedics is paying closer attention to peptides because the field keeps running into the same problem: recovery is biology, but biology still needs evidence before it becomes a protocol.
8mMOTS-c is showing up in cardiac stress research. A new rat-heart study points toward mitochondrial bioenergetics, mtDNA integrity, and post-ischemic recovery.
8mMOTS-c is moving beyond generic energy claims. New research points toward mitochondrial stress response, lung inflammation, and cardiac reperfusion biology.
8mNew 2026 data puts BPC-157 into a sharper recovery frame: oxidative stress, inflammation, apoptosis, angiogenesis, and the limits of animal evidence.
8mBPC-157 finally has a registered human sports-injury study. The signal is important, but it is not proof yet. Here is how to read the trial without the hype.
8mA new sports medicine review puts injury-recovery peptides in context. Some mechanisms are promising, but human evidence, safety data, and regulatory status still matter.
9mA torn meniscus and Baker cyst — both resolved without surgery. This Reddit case report shows what BPC-157 and TB-500 can do for knee injuries. But the clinical picture is more complicated than a success story.
11mBPC-157 and TB-500 are the most researched peptides for connective tissue repair—but combining them requires understanding their different mechanisms. Here's the complete stacking protocol based on actual user experience.
9mKLOW combines BPC-157, TB-500, and GHK-Cu into a single injection. Convenient for maintenance — but knowing when to switch to separate vials can make the difference between results and stalled recovery.
10mBPC-157 and TB-500 are the two most evidence-backed peptides for structural tissue repair. For herniated disc recovery, they work through complementary pathways — here's how to stack them, dose them, and phase in the rest of a recovery protocol.
9m87.5% of patients with chronic knee pain reported significant relief after BPC-157 treatment at the 6–12 month follow-up. Here's a breakdown of the human trial data, the dosing protocol used, and why this peptide is getting serious clinical attention.
10mTB-500 has moved from rodent models to human cardiac recovery trials. The 2026 data is early, but the mechanism and results are worth understanding — especially if you're using TB-500 for recovery.
11mBPC-157 activates multiple tissue repair pathways simultaneously. Users report faster recovery from injury, improved gut healing, enhanced joint mobility—backed by published clinical data.
12mBPC-157 shows promise in clinical research for accelerating tendon repair and recovery. Learn how this peptide works and what the science says about its efficacy.
12mBPC-157 is the most versatile healing peptide available. Here's how it works and how to use it effectively.
12mExplore the healing peptide BPC-157, nicknamed the 'Wolverine peptide' for its remarkable regenerative properties.
Also available at /blog for legacy links.